388 related articles for article (PubMed ID: 7253752)
1. [Renal disease in myeloma. Role of the tumor cell mass (author's transl)].
San Miguel J; Batlle J; Alberca I; Moraleda JM; López Borrasca A
Med Clin (Barc); 1981 Apr; 76(8):347-9. PubMed ID: 7253752
[TBL] [Abstract][Full Text] [Related]
2. [Multiple myeloma with double M-proteins of IgD-lambda and IgA-kappa].
Maruyama Y; Tanikawa S; Sakamaki H; Yahara Y; Onozawa Y; Hayashi Y; Kawaguchi K; Koike M; Ozawa N; Shimizu M
Rinsho Ketsueki; 1987 Aug; 28(8):1475-80. PubMed ID: 3430755
[No Abstract] [Full Text] [Related]
3. Correlation of abnormal immunoglobulin with clinical features of myeloma.
Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
[TBL] [Abstract][Full Text] [Related]
4. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J
Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
Fine JM; Rivat C; Lambin P; Ropartz C
Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
[No Abstract] [Full Text] [Related]
6. Acute phase reactants and clinical stages in multiple myeloma.
San Miguel J; Vicente V; Battle J; Hernandez F; Lopez Borrasca A
Neoplasma; 1981; 28(3):333-8. PubMed ID: 7290260
[TBL] [Abstract][Full Text] [Related]
7. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins.
Isobe T; Osserman EF
N Engl J Med; 1974 Feb; 290(9):473-7. PubMed ID: 4204196
[No Abstract] [Full Text] [Related]
8. [Renal complications of multiple myeloma].
Iványi B
Orv Hetil; 1989 Sep; 130(38):2041-4. PubMed ID: 2797787
[TBL] [Abstract][Full Text] [Related]
9. Bence Jones proteinuria and myeloma kidney.
Chauveau D; Choukroun G
Nephrol Dial Transplant; 1996 Mar; 11(3):413-5. PubMed ID: 8671805
[No Abstract] [Full Text] [Related]
10. [Renal insufficiency due to light chain multiple myeloma].
van Zaanen HC; Diderich PP; Pegels JG; Ruizeveld de Winter JA
Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2133-7. PubMed ID: 11086485
[TBL] [Abstract][Full Text] [Related]
11. [Fanconi syndrome in an adult coincident with early myeloma with monoclonal IgG, type kappa, anomaly (author's transl)].
Walb D; Wohlenberg H; Rumpelt HJ; Schmidt H; Thomas L
Dtsch Med Wochenschr; 1980 Sep; 105(39):1355-9. PubMed ID: 6257469
[TBL] [Abstract][Full Text] [Related]
12. IgD multiple myeloma. Review of 133 cases.
Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma in chronic kidney disease. Utility of discretionary screening using serum electrophoresis.
Doyle A; Soutar R; Geddes CC
Nephron Clin Pract; 2009; 111(1):c7-11. PubMed ID: 19033691
[TBL] [Abstract][Full Text] [Related]
14. [IgD myeloma. Considerations about its diagnosis based on three cases (author's transl)].
López-Aldeguer J; Redón J; González-Molina J; Benedito M; Herranz C; Lacruz J; Navarro JR; Caballero M
Sangre (Barc); 1981; 26(6):1139-44. PubMed ID: 6805083
[No Abstract] [Full Text] [Related]
15. IgD myeloma L-type. Immunochemical study of the first Brazilian case.
Ferri RG; Llach HF; Balthazar P; Cobra CJ; de Souza Júnior JA
Rev Hosp Clin Fac Med Sao Paulo; 1971; 26(6):229-32. PubMed ID: 5006006
[No Abstract] [Full Text] [Related]
16. [Molecular pathology and clinicobiological correlations of IgD myeloma (author's transl)].
San Miguel J; Hernández F; Vicente V; Lasierra J; Sánchez S; López Borrasca A
Med Clin (Barc); 1982 Jan; 78(1):1-4. PubMed ID: 7062796
[No Abstract] [Full Text] [Related]
17. IgD plasma cell neoplasia: clinical manifestations and characteristic features.
Pruzanski W; Rother I
Can Med Assoc J; 1970 May; 102(10):1061-5. PubMed ID: 5000054
[TBL] [Abstract][Full Text] [Related]
18. [IgD myeloma. Massive Bence-Jones proteinuria; effect of the maintaining diuresis].
Gutiérrez Fuentes JA; Fernández Remis JE; Martínez Santos MP; Romero Martínez J
Rev Clin Esp; 1979 Dec; 155(6):443-6. PubMed ID: 545493
[No Abstract] [Full Text] [Related]
19. [Selected renal complications during the course of multiple myeloma].
Sułowicz W; Sydor A; Króliczak M; Ochmański W; Giza D; Stompór T; Wolakiewicz M; Kupaj L
Przegl Lek; 1997; 54(12):835-40. PubMed ID: 9591450
[TBL] [Abstract][Full Text] [Related]
20. Liver disease in multiple myeloma.
Thomas FB; Clausen KP; Greenberger NJ
Arch Intern Med; 1973 Aug; 132(2):195-202. PubMed ID: 4719547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
